Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
28 November 2018 | Story Moeketsi Mogotsi | Photo Moeketsi Mogotsi
Nettah read more
Limpopo-born Law student Anet Matakala’s giant leap of faith by entering the Shoprite Hustler of the Month competition.

Anet Matakala is a Law student who recently had a brilliant, sensational experience when she received recognition as an up-and-coming entrepreneur by Shoprite through their Hustler of the Month Entrepreneur competition.

Matakala is the owner of Nettah Organics, a personal healthcare-product company which uses food-based products to handcraft products for the skin, hair, and body. These products include healthy foodstuffs such as avocados, coffee, green tea, and cinnamon.

She says due to the lack of organic products on the market, she initially made products only for herself. However, in 2017, friends and family started showing interest and she decided to distribute her products among them.

Matakala, who hails from Limpopo, says she formally registered the company in April 2018, while continuing with the same business model.

Making bold moves

The 24-year-old says a friend encouraged her to enter the Shoprite competition after seeing a promo run on social media.

She says signing up for the competition was a leap of faith which yielded results that she hardly expected.

“I was actually playing when I entered. They only responded to me after two months, and at first, I didn’t know that I won; I thought I was just a finalist. A week after that, they told me that they have arranged a photographer to take photos of me and my products. When I asked what it’s for, they told me I had won,” she says.

Her prize as the Shoprite Hustler of October includes a cash prize, sponsored radio marketing, social-media coverage and a crowdfund page for Nettah Organics.

“It [the competition] increased my sales. The competition actually helped me, because a lot of people became interested in my stuff and they started enquiring about them," she adds.

Looking forward, Matakala says she would like to see her products on shelves in retail stores.

News Archive

DNA sequencer launched at the UFS
2013-11-25

Dr Gansen Pillay, Deputy Chief Executive Officer of the National Research Foundation, explaining to the scholars what will be expected of them.

The University of the Free State (UFS) can now collect immensely valuable data on drug resistance in HIV/Aids and TB with the new DNA sequencer that was launched recently at the International workshop on HIV/AIDS and TB drug resistance at the Bloemfontein Campus.

The DNA sequencer will allow the Free State province to produce viral and bacterial genetic data to fight the local development of HIV/ Aids and TB drug resistance.

The HIV and TB epidemics have expanded very fast and South Africa now has the largest HIV and TB treatment programme in the world, with over 2 million patients on treatment. However, these successful treatment programmes are now being threatened by the appearance of drug resistance.

The Free State province has been at the forefront of fighting HIV drug resistance in South Africa and has one of the most advanced treatment programmes for the management of resistance strains in the country. In addition, researchers at the University of the Free State are leading partners in the Southern African Treatment and Resistance Network (SATuRN; www.bioafrica.net/saturn), a research network that has trained over 2 000 medical officers in the treatment of drug resistance strains.

The Department of Medical Microbiology and Virology in the Medical School at the UFS has partnered with the provincial department of health, the Medical Research Council (MRC) and the Delegation of the European Union to South Africa to fund a dedicated DNA sequencer machine that will be used to generate HIV and TB drug-resistance results. This new machine will enable cutting-edge research to take place, using the data in the province and, importantly, support patients with resistance strains to have access to advanced genotypic testing techniques.

“HIV drug resistance is a very serious problem in South Africa, and the recent advances in DNA testing technology allow clinicians in the province to access drug resistance testing, which enables them to manage patients appropriately who fail treatment, and use the results to cost-effectively extend and improve patients’ lives,” says Dr Cloete van Vuuren, Specialist in Infectious Diseases at the UFS’s Faculty of Health.

Dr Dominique Goedhals, pathologist from the Department of Medical Microbiology and Virology at the UFS, adds: “We have been looking forward to expanding our work with the clinicians and researchers, using DNA sequencing to shed light on the causes and consequences of drug resistance in urban and rural settings in the province.”

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept